
### [MONDO:0000119](http://purl.obolibrary.org/obo/MONDO_0000119)
**Label:** congenital heart defects, multiple types

**Subclasses:** [MONDO:0014344](http://purl.obolibrary.org/obo/MONDO_0014344) (congenital heart defects, multiple types, 4), [MONDO:0014000](http://purl.obolibrary.org/obo/MONDO_0014000) (congenital heart defects, multiple types, 2), [MONDO:0013988](http://purl.obolibrary.org/obo/MONDO_0013988) (CHTD3), 

**Mapped go classes:** [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0009956](http://purl.obolibrary.org/obo/GO_0009956) (radial pattern formation), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0001893](http://purl.obolibrary.org/obo/GO_0001893) (maternal placenta development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0060849](http://purl.obolibrary.org/obo/GO_0060849) (regulation of transcription involved in lymphatic endothelial cell fate commitment), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0060674](http://purl.obolibrary.org/obo/GO_0060674) (placenta blood vessel development), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development), [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0045736](http://purl.obolibrary.org/obo/GO_0045736) (negative regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0060852](http://purl.obolibrary.org/obo/GO_0060852) (regulation of transcription involved in venous endothelial cell fate commitment), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0060838](http://purl.obolibrary.org/obo/GO_0060838) (lymphatic endothelial cell fate commitment), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045860](http://purl.obolibrary.org/obo/GO_0045860) (positive regulation of protein kinase activity), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), 

**Class expressions from DL-Learner:**

- [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development) 53.33%
- [GO:0060838](http://purl.obolibrary.org/obo/GO_0060838) (lymphatic endothelial cell fate commitment) 53.33%
- [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation) 53.33%
- [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development) 53.33%
- [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development) 53.33%
- [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development) 53.33%
- [GO:0009792](http://purl.obolibrary.org/obo/GO_0009792) (embryo development ending in birth or egg hatching) 53.33%
- [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development) 53.33%
- [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development) 53.33%
- [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis) 53.33%
- [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development) 53.33%
- [GO:0001893](http://purl.obolibrary.org/obo/GO_0001893) (maternal placenta development) 53.33%
- [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development) 53.33%
- [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development) and [GO:0060135](http://purl.obolibrary.org/obo/GO_0060135) (maternal process involved in female pregnancy) 53.33%
- [GO:0003006](http://purl.obolibrary.org/obo/GO_0003006) (developmental process involved in reproduction) and [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development) and [GO:0060135](http://purl.obolibrary.org/obo/GO_0060135) (maternal process involved in female pregnancy) 53.33%


